Skip to content

a16z Capital Management, L.L.C.

Follow

13F filer, CIK 1540358, MENLO PARK, CA

a16z Capital Management, L.L.C. reported $14,214,935,834 across 19 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-14. Its ten largest share positions make up 99.38% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001540358-26-000010

Period
2026-06-30
Reported value
$14.2B
Holdings
19
Top 10 weight
99.38%
New
4
Sold out
1

Largest buys vs the previous quarter

SecurityShares changeApprox. value
SPCXnew+74,855,020$12.8B
RBLXnew+274,570$14.9M
KLRAnew+140,000$3.08M
IPSTnew+4,137$9.72K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
FIGreduced-10,028,070-$181M
OMDAreduced-1,153,645-$25.3M
NAUTreduced-8,590,863-$16.1M
IPSTexited-82,740-$21.8K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2026

Share positions as resolved from 13F-HR 0001540358-26-000010, largest first. % of portfolio is the value over $14,214,935,834, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
SPCXSPACE EXPLORATION TECHN CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 74,855,020 shares 74,855,020$12.8B89.97%newTimeline
NAVNNAVAN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 27,195,364 shares; 2026Q1: 28,218,676 shares; 2026Q2: 28,218,676 shares 28,218,676$645M4.54%0Timeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 2,748,523 shares; 2024Q4: 2,748,523 shares; 2025Q1: 2,748,523 shares; 2025Q2: 2,748,523 shares; 2025Q3: 2,748,523 shares; 2025Q4: 921,099 shares; 2026Q1: 921,099 shares; 2026Q2: 921,099 shares 921,099$173M1.21%0Timeline
METAMETA PLATFORMS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 212,531 shares; 2025Q4: 212,531 shares; 2026Q1: 212,531 shares; 2026Q2: 212,531 shares 212,531$120M0.84%0Timeline
FIGFIGMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 16,246,129 shares; 2025Q4: 16,246,129 shares; 2026Q1: 16,011,378 shares; 2026Q2: 5,983,308 shares 5,983,308$108M0.76%-10,028,070Timeline
BIOABIOAGE LABS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 3,013,975 shares; 2024Q4: 3,233,170 shares; 2025Q1: 3,233,170 shares; 2025Q2: 3,233,170 shares; 2025Q3: 3,233,170 shares; 2025Q4: 3,233,170 shares; 2026Q1: 3,233,170 shares; 2026Q2: 3,233,170 shares 3,233,170$79.2M0.56%0Timeline
XYZBLOCK INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,016,697 shares; 2024Q4: 1,016,697 shares; 2025Q1: 1,016,697 shares; 2025Q2: 1,016,697 shares; 2025Q3: 1,016,697 shares; 2025Q4: 1,016,697 shares; 2026Q1: 1,016,697 shares; 2026Q2: 1,016,697 shares 1,016,697$77.3M0.54%0Timeline
ERASERASCA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 2,862,500 shares; 2024Q4: 2,862,500 shares; 2025Q1: 2,862,500 shares; 2025Q2: 2,862,500 shares; 2025Q3: 2,862,500 shares; 2025Q4: 2,862,500 shares; 2026Q1: 2,862,500 shares; 2026Q2: 2,862,500 shares 2,862,500$52.4M0.37%0Timeline
MAZEMAZE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 1,702,225 shares; 2025Q2: 1,702,225 shares; 2025Q3: 1,702,225 shares; 2025Q4: 1,702,225 shares; 2026Q1: 1,702,225 shares; 2026Q2: 1,702,225 shares 1,702,225$50.8M0.36%0Timeline
DMRADAMORA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,236,157 shares; 2026Q2: 1,236,157 shares 1,236,157$32.2M0.23%0Timeline
OMDAOMADA HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 4,614,574 shares; 2025Q3: 4,614,574 shares; 2025Q4: 3,460,929 shares; 2026Q1: 2,307,284 shares; 2026Q2: 1,153,639 shares 1,153,639$25.3M0.18%-1,153,645Timeline
NAUTNAUTILUS BIOTECHNOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 17,653,917 shares; 2024Q4: 17,653,917 shares; 2025Q1: 17,653,917 shares; 2025Q2: 17,653,917 shares; 2025Q3: 17,653,917 shares; 2025Q4: 17,653,917 shares; 2026Q1: 17,653,917 shares; 2026Q2: 9,063,054 shares 9,063,054$16.9M0.12%-8,590,863Timeline
RBLXROBLOX CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 274,570 shares 274,570$14.9M0.11%newTimeline
AKTSAKTIS ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 415,000 shares; 2026Q2: 415,000 shares 415,000$13.4M0.09%0Timeline
CAMPCAMP4 THERAPEUTICS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 2,125,339 shares; 2025Q1: 2,125,339 shares; 2025Q2: 2,125,339 shares; 2025Q3: 2,125,339 shares; 2025Q4: 2,125,339 shares; 2026Q1: 2,125,339 shares; 2026Q2: 2,125,339 shares 2,125,339$9.29M0.07%0Timeline
BTGOBITGO HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 666,356 shares; 2026Q2: 666,356 shares 666,356$3.45M0.02%0Timeline
KLRAKAILERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 140,000 shares 140,000$3.08M0.02%newTimeline
DNAGINKGO BIOWORKS HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 108,568 shares; 2024Q4: 108,568 shares; 2025Q1: 108,568 shares; 2025Q2: 108,568 shares; 2025Q3: 108,568 shares; 2025Q4: 108,568 shares; 2026Q1: 108,568 shares; 2026Q2: 108,568 shares 108,568$1.08M0.01%0Timeline
IPSTIP STRATEGY HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 4,137 shares 4,137$9.72K<0.01%newTimeline

Sold out in Q2 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
IPSTIP STRATEGY HOLDINGS INC82,740$21.8Kshares

How Q2 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001540358-26-000010 base2026-08-14acceptance time not in the bulk data set

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13F-HR 0001540358-26-000010 Quarter ended 2026-06-302026-08-14acceptance time not in the bulk data set
13F-HR 0001540358-26-000006 Quarter ended 2026-03-312026-05-15acceptance time not in the bulk data set
13F-HR 0001540358-26-000003 Quarter ended 2025-12-312026-02-17acceptance time not in the bulk data set
13F-HR 0001540358-25-000007 Quarter ended 2025-09-302025-11-14acceptance time not in the bulk data set
13F-HR 0001415889-25-021833 Quarter ended 2025-06-302025-08-14acceptance time not in the bulk data set
13F-HR 0001415889-25-013091 Quarter ended 2025-03-312025-05-15acceptance time not in the bulk data set
13F-HR 0001104659-25-012178 Quarter ended 2024-12-312025-02-12acceptance time not in the bulk data set
13F-HR 0001104659-24-117708 Quarter ended 2024-09-302024-11-13acceptance time not in the bulk data set
13F-HR 0001104659-24-088966 Quarter ended 2024-06-302024-08-13acceptance time not in the bulk data set
13F-HR 0001104659-24-061972 Quarter ended 2024-03-312024-05-15acceptance time not in the bulk data set
13F-HR/A 0001104659-24-061970 Quarter ended 2023-12-312024-05-15acceptance time not in the bulk data set
13F-HR 0001104659-24-023810 Quarter ended 2023-12-312024-02-14acceptance time not in the bulk data set